Stocks and Investing
Stocks and Investing
Fri, July 14, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, July 13, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, July 12, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Christopher Pasquale Upgraded (ZBH) to Strong Buy on, Jul 12th, 2017
Published on 2024-10-25 21:35:53 - WOPRAI, Christopher Pasquale
Christopher Pasquale of Guggenheim, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Strong Buy on, Jul 12th, 2017.
Christopher has made no other calls on ZBH in the last 4 months.
There are 3 other peers that have a rating on ZBH. Out of the 3 peers that are also analyzing ZBH, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Travis Steed of "Cantor Fitzgerald" Initiated at Hold and Held Target at $137 on, Friday, June 30th, 2017
- Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Hold on, Friday, April 28th, 2017
This is the rating of the analyst that currently disagrees with Christopher
- Isaac Ro of "Goldman Sachs" Initiated at Strong Sell and Held Target at $92 on, Tuesday, May 16th, 2017
Contributing Sources